A Mammogram-Free Lifestyle

Cancer was hardly a word in my vocabulary until I came to work for 4Women.com. While I haven’t paid much attention to cancer, as an adult I have always focused attention on environmental carcinogens and other toxins and have done my best to minimize my exposure. That’s me now, but I grew up eating my breakfast seated at a table between two chain-smokers, eating plenty of McDonalds food-like creations, and bathing in, breathing, and absorbing multiple carcinogenic chemicals, especially via all that Lake Michigan salmon we were eating at the height of PCB contamination of the Great Lakes. So it’s a toss. Is my body and future health a picture of my past or current lifestyle?

Surely if I felt marked by my carcinogenic past (and present as there’s no avoiding carcinogens on this poisoned Planet), I’d be requesting monthly mammograms. This year’s annual gyno exam was my first as a 40-yr-old, and I declined what could’ve/would’ve been my first mammogram.

I know. I know. The radiation exposure is minimal, not enough to worry about. That’s what you were told, and that’s what you repeat. I’ve heard it a zillion times, but I don’t buy it. a) There is NO safe level of radiation exposure. b) You’re expecting me to have mammograms every year, on top of all the dental exams I’ve had over my years, on top of all the x-rays I had over the course of 5 broken bones as the risk-taking youth I was - oh, but you didn’t ask about any of that before you proclaimed mammogram radiation levels safe. You seem not to know that radiation exposure is cumulative. You seem to think it’s only the radiation dose of a single exposure that matters, as if the slate is wiped clean and we go back to zero in time for next year’s dose. I know better. I reject your cost/benefit ratio.

Does that mean I do not want to be proactive with regard to screening myself for breast cancer? No! I just don’t want to raise my risk of cancer in the name of finding the cancer. I want safe breast cancer screening alternatives and I’d prefer that all the money going into curing cancer was instead directed towards preventing cancer. The fact that the FDA and other doctors cried out when Dr. Mercola made a positive statement about the use of breast themography for monitoring breast health was not lost on me. Someone’s profits were in jeopardy.

So while the news buzzes about mammogram rates going down since last year’s new Task Force mammogram recommendations, I’m feeling like less of an outlier, even if my reasoning remains on the outskirts.

Michelle Young, 4Women.com, Research and Communications Director

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap